Alpha Cubed Investments LLC Holds Position in Mesa Laboratories, Inc. (MLAB)

Alpha Cubed Investments LLC continued to hold its position in Mesa Laboratories, Inc. (NASDAQ:MLAB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,970 shares of the medical instruments supplier’s stock at the end of the second quarter. Alpha Cubed Investments LLC owned 0.08% of Mesa Laboratories worth $426,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Strs Ohio boosted its position in Mesa Laboratories by 5.6% in the second quarter. Strs Ohio now owns 1,900 shares of the medical instruments supplier’s stock valued at $272,000 after buying an additional 100 shares in the last quarter. Eqis Capital Management Inc. boosted its position in shares of Mesa Laboratories by 5.6% in the second quarter. Eqis Capital Management Inc. now owns 5,188 shares of the medical instruments supplier’s stock worth $744,000 after buying an additional 273 shares during the period. Pembroke Management LTD bought a new position in shares of Mesa Laboratories during the second quarter worth about $8,283,000. Finally, Thomson Horstmann & Bryant Inc. boosted its position in shares of Mesa Laboratories by 75.4% in the second quarter. Thomson Horstmann & Bryant Inc. now owns 72,362 shares of the medical instruments supplier’s stock worth $10,370,000 after buying an additional 31,107 shares during the period. Institutional investors and hedge funds own 67.11% of the company’s stock.

Mesa Laboratories, Inc. (NASDAQ:MLAB) opened at 129.98 on Friday. The stock has a market cap of $488.46 million, a P/E ratio of 46.72 and a beta of 0.46. The stock has a 50 day moving average of $142.50 and a 200-day moving average of $136.41. Mesa Laboratories, Inc. has a 52 week low of $103.29 and a 52 week high of $169.80.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings data on Monday, July 31st. The medical instruments supplier reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.56 by $0.17. Mesa Laboratories had a return on equity of 16.58% and a net margin of 11.31%. The firm had revenue of $22.67 million for the quarter, compared to the consensus estimate of $22.90 million. Analysts forecast that Mesa Laboratories, Inc. will post $2.72 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Thursday, August 31st will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.49%. The ex-dividend date of this dividend is Tuesday, August 29th. Mesa Laboratories’s payout ratio is 22.94%.

WARNING: This article was published by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://www.com-unik.info/2017/08/19/mesa-laboratories-inc-mlab-stake-held-by-alpha-cubed-investments-llc-updated-updated.html.

A number of research analysts have recently weighed in on the stock. Zacks Investment Research cut shares of Mesa Laboratories from a “buy” rating to a “strong sell” rating in a research note on Thursday, August 3rd. BidaskClub lowered shares of Mesa Laboratories from a “hold” rating to a “sell” rating in a report on Monday, July 31st. Finally, TheStreet downgraded shares of Mesa Laboratories from a “b” rating to a “c+” rating in a research note on Monday, July 31st.

In other Mesa Laboratories news, Director Robert V. Dwyer sold 11,150 shares of the firm’s stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $139.46, for a total transaction of $1,554,979.00. Following the sale, the director now directly owns 80,671 shares in the company, valued at approximately $11,250,377.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Glenn E. Adriance sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $148.98, for a total transaction of $595,920.00. Following the sale, the insider now owns 10,000 shares in the company, valued at $1,489,800. The disclosure for this sale can be found here. Insiders have sold a total of 21,760 shares of company stock worth $3,078,708 in the last three months. 17.00% of the stock is owned by insiders.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

What are top analysts saying about Mesa Laboratories Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mesa Laboratories Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit